Tracon Pharmaceuticals, Inc.·4

Mar 2, 6:24 AM ET

THEUER CHARLES 4

4 · Tracon Pharmaceuticals, Inc. · Filed Mar 2, 2023

Insider Transaction Report

Form 4
Period: 2023-02-28
THEUER CHARLES
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-02-28$1.52/sh+200$304340,118 total
  • Purchase

    Common Stock

    2023-03-01$1.52/sh+4,800$7,296344,918 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION